[go: up one dir, main page]

BRPI0501120A - composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos - Google Patents

composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos

Info

Publication number
BRPI0501120A
BRPI0501120A BRPI0501120A BRPI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
solubilizing agents
high concentrations
oral
Prior art date
Application number
Other languages
English (en)
Inventor
Henry Jun Suzuki
Original Assignee
Henry Jun Suzuki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry Jun Suzuki filed Critical Henry Jun Suzuki
Priority to BRPI0501120 priority Critical patent/BRPI0501120A/pt
Priority to ARP060100572A priority patent/AR053333A1/es
Priority to PCT/BR2006/000027 priority patent/WO2006086864A1/en
Publication of BRPI0501120A publication Critical patent/BRPI0501120A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS ORAIS E PARENTERAIS CONTENDO ALTAS CONCENTRAçõES DE AGENTES SOLUBILIZANTES AROMáTICOS". A presente invenção consiste de composições farmacêuticas contendo uma quantidade significativa de ingredientes ativos dissolvidos em fase oleosa, caracterizadas por conterem altas concentrações de agentes solubilizantes aromáticos, bem como processos de manufatura de tais composições. Mais especificamente, compreende composições farmacêuticas orais ou parenterais contendo uma quantidade significativa de ingredientes ativos dissolvidos em fase oleosa, caracterizadas por conterem agentes solubilizantes aromáticos numa quantidade superior a 10% em massa em relação aos demais excipientes presentes na fase oleosa.
BRPI0501120 2005-02-18 2005-02-18 composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos BRPI0501120A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0501120 BRPI0501120A (pt) 2005-02-18 2005-02-18 composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
ARP060100572A AR053333A1 (es) 2005-02-18 2006-02-17 Composiciones farmaceuticas orales y parenterales que contienen altas concentraciones de agentes solubilizantes aromaticos
PCT/BR2006/000027 WO2006086864A1 (en) 2005-02-18 2006-02-20 Pharmaceutical compositions comprising aromatic solubilizing agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0501120 BRPI0501120A (pt) 2005-02-18 2005-02-18 composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos

Publications (1)

Publication Number Publication Date
BRPI0501120A true BRPI0501120A (pt) 2006-10-03

Family

ID=36916128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0501120 BRPI0501120A (pt) 2005-02-18 2005-02-18 composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos

Country Status (3)

Country Link
AR (1) AR053333A1 (pt)
BR (1) BRPI0501120A (pt)
WO (1) WO2006086864A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
US8173169B2 (en) 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
WO2024014959A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Micelle-generating formulations with improved hydrophobicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132518A (en) * 1965-02-18 1968-11-06 Richardson Merrell Inc Medicinal composition
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
CN100500651C (zh) * 2000-07-27 2009-06-17 特瓦制药工业有限公司 晶体和纯莫达非尼及其制备方法
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine

Also Published As

Publication number Publication date
AR053333A1 (es) 2007-05-02
WO2006086864A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
EA201490489A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
MX2010007523A (es) Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer.
NI200800299A (es) Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias.
CO6331340A2 (es) Pirrolo-pirimidinas y pirrolo piridinas
MA32442B1 (fr) Inhibiteurs de la syk protéine kinase
PT1951730E (pt) Derivados de pirimidina ligados a heteroalquilo
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
BR112012018384A2 (pt) composição farmacêutica sólida com intensificadores e métodos de preparação da mesma.
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MX357759B (es) Formulaciones y formas de dosificacion de fosfolipidos oxidados.
BRPI0801239A2 (pt) uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
EA200900582A1 (ru) Фармацевтические композиции для профилактики и лечения глазных патологий
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
PL1965809T3 (pl) Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
BRPI0501120A (pt) composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
EA200900742A1 (ru) Производные аминохиназолина с понижающими тромбоциты свойствами
WO2006071564A3 (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
BRPI0912092A2 (pt) quinazolinas substituídas
WO2007002897A3 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired